Wordt geladen...
Protease‐activated receptor 4: from structure to function and back again
Protease‐activated receptors are a family of four GPCRs (PAR1–PAR4) with a number of unique attributes. Nearly two and a half decades after the discovery of the first PAR, an antagonist targeting this receptor has been approved for human use. The first‐in‐class PAR1 antagonist, vorapaxar, was approv...
Bewaard in:
| Gepubliceerd in: | Br J Pharmacol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341247/ https://ncbi.nlm.nih.gov/pubmed/26844674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13455 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|